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Characterization of the migration of lung and blood T cells
in response CXCL12 in a three-dimensional matrix
Introduction
T lymphocytes play a central role in the immune system
as both effectors and regulators of the immune response.
Throughout the lifespan of a T cell, the ability to migrate
to and within lymphoid organs is necessary for survival
and function. The lung harbours a large pool of T cells,
which reside in the bronchial lamina propria, the alveolar
walls and the interstitium.
1 Lung T cells are phenotypi-
cally different from blood T cells, a majority being mem-
ory T cells expressing the activation markers CD69,
CD103 and CD49a.
2 Lung-resident T cells are involved in
the defence against the large number of inhaled patho-
gens. Hence, recruitment to, and microlocalization within,
the lung is crucial for immune surveillance. However,
T-cell inﬁltration is also a feature of many inﬂammatory
lung conditions such as asthma and sarcoidosis.
3,4
T cells re-circulate from blood to tissue in an organ-
speciﬁc manner with a bias for memory cells to return to
the organ where they encountered their cognate antigen,
a process termed lymphocyte homing.
5 This process is
controlled by a combination of adhesion and chemokine
receptors on speciﬁc T-cell subsets binding to their
ligands, which are expressed on post-capillary venule
endothelium in an organ-speciﬁc manner. Whereas naive
cells circulate only from blood to lymph nodes in a ran-
dom fashion, memory cells can also enter other organs,
particularly of mucosal origin, where they accumulate in
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Summary
The ability of T cells to microlocalize within tissues, such as the lung, is
crucial for immune surveillance and increased T-cell inﬁltration is a fea-
ture of many inﬂammatory lung conditions. T-cell migration has mainly
been studied in two-dimensional assays. Using three-dimensional collagen
gels to mimic the extracellular matrix of lung tissue, we have character-
ized the migration of T lymphocytes isolated from peripheral blood
(PBT) and lung (LT) in response to interleukin-2 (IL-2) and CXCL12.
Freshly isolated PBT and LT showed a low degree of migration (blood
40±1 3% and lung 41±1 7%). Twenty-four hours of culture increased
the percentage of migrating PBT and LT (blood 175±2 9% and lung
177±3 8%). The IL-2 stimulation modestly increased migration of PBT
after 6 days (323±6 0%), but had no effect on the migration of LT
(255±3 2%). Twenty-four hours of stimulation with anti-CD3/CD28
caused a small but signiﬁcant increase in the migration of PBT (to
364±5 8%). In a directional three-dimensional assay, CXCL12 failed to
induce migration of fresh PBT or LT. Twenty-four hours of culture,
which increased CXCR4 expression of PBT 36-fold, signiﬁcantly increased
the migration of PBT in response to CXCL12. Migration of PBT to
CXCL12 was blocked by pertussis toxin, but not by the phosphoinositide
3-kinase inhibitor wortmannin. Twenty-four-hour cultured LT did not
respond to CXCL12. CD3/CD28-stimulation inhibited CXCL12-mediated
migration of PBT. These results suggest that the migration pattern of
PBT is distinct from that of LT.
Keywords: chemokine; CXCL12; lung; migration; T cell
Abbreviations: 2D, two-dimensional; 3D, three-dimensional; GDP, guanosine diphosphate; GTP, guanosine triphosphate; IL-2,
interleukin-2; PI3K, phosphoinositide 3-kinase; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; TCR, T-cell receptor.
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ately on entering tissue migrate to the lymph nodes, and
then to the blood, and the extent to which they become
resident in the tissue, is not known. However, a signiﬁ-
cant proportion of tissue T cells (unlike blood cells)
express receptors such as CD49a, which are only
expressed some weeks after activation, suggesting that
these T cells at least are resident for a signiﬁcant period.
These resident memory T cells form a pool of antigen-
speciﬁc cells that are strategically located for a rapid
response to the antigen against which they are targeted.
Although a great deal is known about the steps control-
ling migration of T cells from the blood into the tissue,
very little is known about the signals that control com-
partmentalization in tissue. One problem in understand-
ing this process is that to study tissue-speciﬁc migration
you should be using tissue T cells, which are not readily
available.
In vitro, T cells have been shown to migrate in response
to a variety of stimuli, such as T-cell receptor (TCR) acti-
vation, growth factors and chemokines. Like other leuco-
cytes, T cells migrate in an amoeboid fashion, which
means that a small protrusion forms a leading edge at the
front of the cell; the cell body containing the nucleus is
in the middle and an elongated uropod is at the rear.
6
For this tightly regulated cell polarization to occur, the
molecular processes in the front of the cell must be com-
partmentalized. This is thought to be achieved and main-
tained in part through the action of Rho-family guanine
triphosphate (GTP)ases.
Most studies investigating T-cell migration have been
conducted in two-dimensional (2D) assays (collagen or
ﬁbronectin-coated microscope slides or Boyden cham-
bers), but the mechanisms used for migration within the
three-dimensional (3D) environment of the lung tissue
are likely to be different. For example, leucocyte migra-
tion over a 2D surface requires integrin adhesion, whereas
rapid migration in a 3D matrix is integrin-independent
and the cell migrates forward by pushing and squeezing
itself forward between the matrix ﬁbres.
7
Collagen is one of the main components of the extra-
cellular matrix and intravital microscopy has shown that
leucocytes have a similar migration pattern in 3D collagen
gels to that in vivo in peripheral tissues.
8 We have there-
fore used collagen gels to mimic the extracellular matrix of
the lung to characterize the migration of human T lym-
phocytes isolated from peripheral blood and lung in
response to the T-cell growth factor interleukin-2 (IL-2)
and the chemokine CXCL12. CXCL12 is a potent T-cell
chemokine.
9 It has one known activating receptor, CXCR4,
which is expressed on almost all T cells.
10 CXCL12 is also
expressed constitutively in the lung,
9,11 making it a suit-
able mediator to study chemokine-induced migration of T
cells in a 3D collagen matrix environment. Although
CXCL12 is not considered an inﬂammatory chemokine, a
mouse model of allergic airway disease found a role for
CXCL12 in the development of lung inﬂammation.
12
Hoshino et al.
13 found increased expression of CXCL12 in
asthmatic patients compared with normal controls.
CXCL12 is also expressed constitutively in the lung.
9 There
are no previous studies investigating the migration of
human lung T cells in a 3D assay. However, we have
developed a method to purify sufﬁcient numbers of viable
lung T cells to investigate lung T-cell migration.
14
In this study, we found that 24-hr cultured blood T
cells migrated signiﬁcantly towards CXCL12 in a dose-
dependent manner, whereas lung T cells and blood T cells
stimulated with CD3/CD28 beads did not. The Gai inhib-
itor pertussis toxin, but not the phosphoinositide 3-kinase
(PI3K) inhibitor wortmannin, blocked this migration.
Materials and methods
Cells
All patients and healthy volunteers gave written informed
consent and the study was approved by the Leicestershire
Research Ethics Committee. CD3
+ T cells were puriﬁed
from peripheral blood from healthy volunteers, using
Histopaque 1077 (Sigma, Sigma-Aldrich Company LTD,
Poole, Dorset, UK) and immunomagnetic sorting for
CD3 (Miltenyi Biotech, Surrey, UK) according to the
manufacturer’s instructions. Lung T cells were puriﬁed
from lung resection tissue obtained from patients under-
going surgery for carcinoma at the Glenﬁeld Hospital in
Leicester, UK, according to a previously described
method.
14 Brieﬂy, the lung specimen was ﬁnely chopped
and ﬁltered through gauze. T cells were then puriﬁed
from the resulting ﬁltrate using a discontinuous 40/70%
Percoll gradient and positive selection of CD3
+ cells by
immunomagnetic sorting. The viability of the puriﬁed
cells was > 95%. The purity of the T cells used in the
migration assays was over 95% for blood and between 80
and 95% for lung T cells. The contaminating cells in the
lung T-cell preparations were macrophages, which could
be easily excluded from the analysis of migration because
of their size.
Migration in 3D collagen gels
The T cells (at 5 · 10
6 cells/ml) were incorporated into
collagen gels and ﬁlmed using OPENLAB software (Improvi-
sion, Coventry, UK) and an inverted microscope as previ-
ously described.
15 T-cell migration was analysed using
VOLOCITY software (Improvision). Cells that were tracked
for less than 60 seconds and duplicate tracks of the same
cell were excluded from analysis. A migration index was
calculated as the percentage of tracks that had a total dis-
placement from the point of origin of more than 10 lm.
A threshold of 10 lm was chosen because this avoided
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T-cell migration in 3D in response to CXCL12counting cells that moved on the spot and the percentage
of migrating cells was used rather than distance migrated
because many cells during the course of the experiment
migrated into the gel and were lost from view. The veloc-
ity of migration was also recorded for some experiments.
Stimuli: CD3/CD28-conjugated Dynal beads (Invitrogen,
Paisley, UK) were used according to the manufacturer’s
instructions. Interleukin-2 (R&D Systems, Oxford, UK)
was used at 4 ng/ml for 24 hr, 48 hr and 5–6 days at 37 .
In the directional migration assay, the gel chamber was
ﬁlled to 75% with the cell–collagen mixture, which was
allowed to polymerize. CXCL12 (R&D Systems) was then
added suspended in phosphate-buffered saline at one side
of the gel, immediately before the chamber was sealed
and the edge of the gel closest to the chemokine was
ﬁlmed.
Inhibitors: Cells were pre-treated with inhibitors before
being added to the collagen. Pertussis toxin (100 ng/ml;
Sigma), 2 hr at 37 . Wortmannin (50 nM; MERCK Chem-
icals, Nottingham, UK) and Diprotin A (50 nM; Sigma)
30 min at 37 . The viability of the cells, as determined
with trypan blue, was not altered by treatment with any
of the inhibitors.
Flow cytometry
Antibodies: CXCR4 (10 l/ml) (R&D Systems), ﬂuorescein
isothiocyanate-conjugated polyclonal rabbit anti-mouse
(1 : 10; Dako Cytomation, Cambridge, UK), phycoery-
thrin-conjugated CD26 (1 : 200; Invitrogen) phycoery-
thrin-Cy5.5-conjugated CD3 (1 : 200; Caltag) and
phycoerythrin-conjugated CD3 (1 : 200; BD Biosciences,
Oxford, UK). Cells were stained as previously described
and acquired in a FACSCanto ﬂow cytometer (BD Bio-
sciences). The results were analysed by FACSDIVA software
(BD Biosciences).
Western blotting
Blood T cells cultured for 24 hr were exposed to the fol-
lowing conditions: (i) untreated, (ii) 100 ng/ml of
CXCL12 for 30 min, (iii) pre-treatment 00025% of
dimethyl sulphoxide for 30 min + 100 ng/ml for 30 min
or (iv) pre-treatment 50 nM wortmannin + 100 ng/ml
CXCL12 for 30 min. The cells were pelleted and lysed in
Laemmli buffer (Sigma) diluted 1 : 2 in distilled water.
The lysates were boiled for 5 min and run on a 10%
sodium dodecyl sulphate–polyacrylamide gel electropho-
resis gel. The proteins were then electro-transferred to
Immobilion P transfer membranes (Millipore, Watford,
UK). After blocking for 1 hr in 5% milk, the membranes
were probed with rabbit anti-human Phospho-Akt
antibody (1 : 1000) (Cell Signaling Technology, Danvers,
MA) in 5% bovine serum albumin washed, followed by
1 lg/ml of horseradish peroxidase-conjugated polyclonal
swine anti-rabbit-horseradish peroxidase antibody in 5%
milk. For detection, enhanced chemiluminescence reagent
(GE Healthcare Life Sciences, Little Chalfont, Bucking-
hamshire, UK), was used. Total Akt was used as a loading
control, using the same staining protocol on stripped
membranes.
Statistical analysis
To test differences between two groups, Student’s t-test
was used, whereas one-way analysis of variance (ANOVA)
and Bonferroni’s post test were used to test differences
among three or more groups.
Results
Freshly isolated T cells do not migrate spontaneously
When freshly isolated T cells from blood or lung were
incorporated into 3D collagen gels in a non-gradient
assay in the absence of any chemotactic signal, only a very
few cells migrated (blood 40±1 3%, n = 14 lung
41±1 7%, n = 15). After 24-hr culture in medium there
was a signiﬁcant increase in migration of both lung and
blood T cells although still only a minority of cells dem-
onstrated migratory behaviour (blood 175±2 9%,
P <0 05 n = 14; lung 177±3 8%, P <0 001, n = 15)
(Fig. 1a,b). Similar results were obtained when the cells
were cultured in serum-free medium (data not shown).
There were no signiﬁcant differences between the lung
and blood T cells in the percentage of migrating cells or
in the velocity of migration (745 ± 09 lm/min versus
806 ± 19 lm/min, P =0 40). Cells migrated in a non-
directional manner (Movie S1).
IL-2 stimulation
Stimulation of peripheral blood T cells with IL-2 resulted
in a small increase in migration, which only reached
signiﬁcance compared with spontaneous migration after
between 5–6 days in culture (177±5 0% versus 323±
60%, P <0 05, n = 5) (Fig. 2a). In contrast stimulation
of lung T cells had no effect on migration compared with
control at any time-point (283±5 2% versus 255±
32%, n = 8) (Fig. 2b).
T-cell migration in response to CXCL12
To investigate the migration of T cells towards a chemo-
kine in the 3D collagen matrix, we exposed the T cells to
CXCL12 in a modiﬁcation of the non-directional assay in
which the chemokine was placed on one side of the gel
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attractant gradient. Freshly isolated blood T cells were
unable to migrate towards CXCL12, (45±2 2% versus
62±2 1%, n = 4). After 24 hr of culture, which resulted
in a 36-fold up-regulation of CXCR4 (data not shown), a
large proportion of blood T cells migrated in response to
CXCL12 with an optimal concentration of 100 ng/ml
(673±5 30%, n = 4; Fig. 3a). Blood T cells responded
to CXCL12 by migrating in a directional manner towards
the chemoattractant gradient, as seen in a vector diagram
of the pattern of movement of the individual cells
(Fig. 3b and Movie S2). Neither freshly isolated nor 24-hr
cultured lung T cells demonstrated signiﬁcant migration
in response to 100 ng/ml of CXCL12 (163 ± 08 versus
273 ± 16%, n = 3 and 1175 ± 32 versus 2124 ± 60%,
P =0 22, n = 4, respectively) (data not shown).
Stimulation with CD3/CD28
Stimulation of blood T cells with CD3/CD28 beads for
24 hr caused a signiﬁcant although modest increase in
random migration in the non-gradient assay
(364±5 8%, versus 1837 ± 31%, P <0 05, n = 10;
Fig. 4). We then investigated the effect of CXC12 in a
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Figure 2. (a) The percentage of blood T cells migrating within three-dimensional collagen gels after 6 days of interleukin-2 (IL-2) stimulation
compared with the unstimulated control (n =5 ,P < 0.05). (b) Migration of lung T cells within three-dimensional collagen gels after 5 days of
IL-2 stimulation compared with the unstimulated control (n =8P > 0.05).
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Figure 1. Effect of 24-hr culture of (a) blood T cells (n = 14) and (b) lung T cells (n = 15) on the percentage of spontaneously migrating cells
within three-dimensional collagen gels (blood 17.5 ± 2.9% and lung, 17.7 ± 3.8.0%), compared with when freshly isolated (4.0 ± 1.2%,
P < 0.001 and 4.1 ± 1.7%, P < 0.05, respectively). (c) Vector diagram showing random movements of spontaneously migrating 24 hr cultured
blood T cells.
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Figure 3. (a) Migration of blood T cells in response to CXCL12 in a gradient migration assay. Concentration response of CXCL12 for the migra-
tion of 24-hr cultured blood T cells (n = 4). (b) Representative vector diagram showing the direction of migration by 24-hr cultured blood T
cells in response to a gradient of 100 ng/ml CXCL12. The chemokine was added to the right side of the gel.
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T-cell migration in 3D in response to CXCL12gradient assay on CD3/CD28 stimulated T cells. However,
CD3/CD28 stimulation prevented the blood T-cell
response to the CXCL12 gradient (356±5 7%, P <
0001, n = 5; Fig. 4), without down-regulating CXCR4
(data not shown).
CD26 expression and inhibition
The surface molecule CD26 (DPPIV) is an activation
marker with dipeptidyl peptidase activity in its extracellu-
lar domain. This enzyme cleaves the N-terminal dipep-
tides from a protein containing either L-proline or
L-alanine at the penultimate position, including CXCL12.
16
We therefore investigated if the enzymatic activity of this
protein was the reason why lung T cells were constitu-
tively unresponsive to CXCL12 and why CD3/CD28 stim-
ulation rendered the blood T cells unresponsive to
CXCL12. The majority of lung (753±6 7%, n = 4) and
blood (777% n = 1 with CD3/CD28 activation and
756% n = 2 without activation) T cells expressed CD26.
However, inhibition of CD26 activity by Diprotin A did
not increase the migration in response to CXCL12 of
either lung T cells or activated blood T cells (data not
shown).
Pertussis toxin, but not wortmannin, inhibits
CXCL12-induced migration
Migration in response to CXCL12 in the gradient assay
was completely blocked when 24-hr cultured blood T cells
were pre-treated with pertussis toxin, conﬁrming that the
Gai subunit of the G-protein coupled receptor is involved
in CXCL12-mediated migration in our model (Fig. 5a).
In contrast, inhibition of PI3K activity with wortmannin
had no effect of CXCL12-induced migration of blood T
cells (Fig. 5b), although Western blotting showed that the
PI3K product phospho-Akt increased after stimulation
with CXCL12 and that this was blocked when the cells
had been treated with wortmannin before stimulation
(Fig. 5c).
Discussion
T-cell trafﬁcking through the lung is important for
immune surveillance and host defence but inappropriate
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Figure 5. Migration (% migrating > 10 lm) of 24-hr cultured blood T cells migrating when exposed to a 100 ng/ml gradient of CXCL12 after
pre-treatment with (a) pertussis toxin (100 ng/ml) for 2 hr or (b) wortmannin (50 nm) for 30 min (n = 3 and n = 5, respectively). (c) Western
blot for phospho-Akt of 24-hr cultured blood T cells lysed after the following treatments (i) Untreated and unstimulated. (ii) Untreated and
stimulated with 100 ng/ml of CXCL12 for 30 min. (iii) Pre-treated with 00025% dimethylsulphoxide (DMSO) for 30 min before stimulation
with 100 ng/ml of CXCL12 for 30 min. (iv) Pre-treated with 50 nm wortmannin for 30 min before stimulation with 100 ng/ml of CXCL12 for
30 min (n = 3).
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C. E. Day et al.T-cell activation is associated with a number of inﬂam-
matory lung diseases.
17 The factors controlling migration
of lung T cells in lung tissue are therefore of considerable
interest. Lung T cells are quite distinct from peripheral
blood T cells in particular in terms of adhesion, activation
and chemokine receptor expression.
1,2 The migratory
behaviour of tissue-derived T cells is therefore more rele-
vant to the physiology of T-cell migration in tissue than
that of peripheral blood T cells but the migratory behav-
iour of human tissue-derived T cells is rarely studied.
This is the ﬁrst study we are aware of that has investi-
gated the migratory pattern of lung T cells or indeed tis-
sue T cells from any source in an assay of migration that
attempts to model the tissue matrix environment. We
have demonstrated that unlike blood T cells, lung T cells
were unable to respond to the growth factor and chemo-
kine-activating stimuli IL-2 and CXCL12. In addition, we
demonstrated that migration of peripheral blood T cells
to CXCL12 was inhibited by activation through the TCR.
Migration to the chemokine was pertussis toxin depen-
dent but independent of PI3K. These data are consistent
with a model in which tissue T cells which encounter
cognate antigen become unresponsive to migration stim-
uli and so become resident in the tissue for prolonged
periods.
Immediately after isolation, both lung and blood T cells
failed to migrate either spontaneously or in response to
CXCL12 (Fig. 1 and data not shown). The cause of the
lack of responsiveness of freshly isolated T cells and
whether this has any in vivo signiﬁcance is not clear but
may be simply the result of an effect of being kept at 4 
for several hours during the puriﬁcation procedure. How-
ever, in one experiment using the Boyden chamber,
freshly isolated blood cells migrated to CXCL12, although
migration was less than cells cultured overnight in med-
ium (40% versus 99%). This suggests that as well as an
effect of the isolation procedure, cells were less able to
migrate in the 3D environment compared with the 2D
environment. The reasons for this are not clear, although
they may be associated with the relative unimportance of
adhesion receptors in the 3D assay. After 24 hr in culture,
both lung and T cells migrated spontaneously to a similar
degree with up 40% of cells demonstrating random
migration. This did not appear to be the result of factors
in fetal calf serum because spontaneous migration also
occurred after culture in serum-free media.
Eosinophils do not migrate spontaneously in the 3D
collagen assay but show vigorous random migration in
response to the growth factor granulocyte–macrophage
colony-stimulating factor after only a few minutes of
stimulation.
15 We therefore hypothesized that IL-2, an
archetypal T-cell growth factor, would have the same
effect. However, IL-2 at a universally established effective
dose had only a modest effect on the migration of blood
T cells compared with spontaneous migration, which was
only signiﬁcant after 5 days and there was no effect at all
on lung T-cell migration. Similar data to puriﬁed blood
CD3 cells were obtained with peripheral blood mononu-
clear cells obtained without magnetic bead puriﬁcation
(data not shown) suggesting that the response to IL-2 was
not inﬂuenced by the method of puriﬁcation. Similarly
another activating stimulus, CD3/CD28, had only a mod-
est effect on blood T-cell migration. It was not possible
to stimulate lung T cells through CD3 because they were
puriﬁed using positive selection with anti-CD3 antibody.
In contrast to IL-2 a robust response was seen with
CXCL12. CXCL12 is a potent T-cell chemokine and its
receptor is expressed by almost all T cells, making it a
good candidate for comparing the response of blood and
lung T cells to chemokines in our system. CXCL12 is also
constitutively expressed in the lung.
9,11 CXCL12 had a
marked and consistent chemotactic effect on blood T cells
after 24 hr in culture. The difference between the
response of freshly isolated and 24-hr cultures of blood T
cells may be the result of a marked up-regulation of
expression of the receptor for CXCL12, CXCR4. The
expression of CXCR4 on freshly puriﬁed blood cells was
the same as expression on the T cell before puriﬁcation,
showing that the receptor was not shed or down-regu-
lated during puriﬁcation (data not shown). Lung T cells
that highly expressed CXCR4 did not respond effectively
to CXCL12 even after overnight culture.
We cannot exclude the possibility that the differences
between the lung and blood T cells were the result of
either differences in the source of these cells or the
method of puriﬁcation. We were unable for logistical rea-
sons to obtain matched samples and the lung cells were
from patients undergoing resection for lung cancer
whereas the blood cells were from healthy volunteers.
However, patients undergoing lung resection are generally
healthy with only minimal smoking-related airways dis-
ease and early-stage malignancy and it seems unlikely that
their blood cells would behave in a fundamentally differ-
ent way to those from healthy volunteers. The puriﬁca-
tion methods were similar involving immunomagnetic
selection although selection was positive for the lung T
cells. However, the beads used are not thought to stimu-
late T-cell activation.
In vivo T cells are likely to be exposed to both activat-
ing and migratory stimuli. We therefore investigated the
response of blood T cells stimulated with both anti-CD3/
CD28-conjugated beads for 24 hr and CXCL12. Perhaps
surprisingly, stimulation with anti-CD3/CD28 rendered
the cells unresponsive to CXCL12. One explanation for
this result may be that the activation status of the T cells
affected their response to chemokines. A majority of lung
T cells are activated effector/memory T cells.
2 A cross-talk
between the TCR and CXCR4 has been described by Pea-
cock et al.,
18 who showed that TCR-stimulation reduced
chemotaxis to CXCL12 and conversely that CXCL12
  2010 Blackwell Publishing Ltd, Immunology, 130, 564–571 569
T-cell migration in 3D in response to CXCL12inhibited TCR-mediated signalling pathways. The two sig-
nalling pathways were shown to converge at protein
kinase C or phospholipase Cb3, which phosphorylated
CXCR4, triggering its desensitization for CXCL12. This
cross-talk might explain the lack of migration of the in
vitro-activated blood T cells to CXCL12 and could possi-
bly also affect the migration of lung T cells.
We investigated the possibility that up-regulation of the
dipeptidase CD26 on activated T cells might destroy the
CXCL12 gradient by proteolytic cleavage. However, ﬂow
cytometry of CD26 showed no difference in the CD26
expression between unstimulated blood T cells, CD3/
CD28-stimulated blood T cells and lung T cells. Nor did
inhibition of CD26 using Diprotin A restore chemotaxis
of lung T cells or activated blood T cells to CXCL12 sug-
gesting that CD26 is not responsible for the inhibition of
chemotactic responses to CXCL12 by activated T cells in
our 3D migration assay.
It is not clear how the signal mediated by CXCL12 is
transduced from CXCR4 to the migratory machinery of T
cells migrating within a three-dimensional environment.
As expected, the chemotactic migration of blood T cells to
a CXCL12 gradient was completely inhibited by pertussis
toxin, which conﬁrms that G proteins containing the Gai
are crucial for chemokine-mediated migration in our 3D
collagen gel model. Chemokine receptor engagement
triggers the exchange of GDP to GTP on the Gai subunit,
which causes the heterotrimeric G protein to disassemble
into the Gai and b/c subunits. These then propagate effects
downstream of the receptor, ultimately leading to polariza-
tion of the cell and subsequent migration towards the
chemokine.
19 A fairly shallow chemokine gradient of
< 10% difference in concentration between front and back
of the cell can still cause directional movement. This is
thought to be possible because of gradient amplifying Rho
GTPases. Rac and Cdc42 at the front of the cell activate
Wiskott-Aldrich syndrome protein (WASp) and WASp-
family verprolin homologous protein, respectively, which
in turn mediate actin polymerization through the Arp2/3
complex.
20,21 Rac is thought to be involved in a positive
feedback loop with PI3K/phosphatidyl inositol 3,4,5-tri-
phosphate (PIP3),
22,23 whereas Rho is more active at the
rear where it is, for example, involved in the retraction of
the uropod.
24 Rho also activates phosphatase and tensin
homolog, a PIP3 dephosphatase, which counteracts PI3K
at the rear and so ampliﬁes the polarization.
25 For this rea-
son, PI3K is considered a central molecule in chemotactic
migration. It was therefore surprising to ﬁnd that inhibit-
ing PI3K with wortmannin had no effect on blood T-cell
migration to CXCL12. The same lot of the inhibitor was
efﬁcient in inhibiting neutrophil migration to CXCL8 in
the same 3D gradient assay (manuscript in preparation).
We also showed that up-regulation of the PI3K product
phospho-Akt was inhibited when the cells had been
pre-treated with wortmannin, conﬁrming the effect of the
inhibitor. It is interesting that although PI3K is clearly
activated by CXCL12, it is dispensable for the migration
towards this chemokine in 3D collagen gels. It has been
suggested that DOCK2, which has been shown to be essen-
tial for the chemotaxis of T cells to CXCL12 in a transwell
chemotaxis assay, can act as a Rac guanine nucleotide
exchange factor independently of PI3K.
26,27 The activity of
DOCK2 might explain why blood T cells were able to
migrate in response to the CXCL12 gradient although
PI3K was inhibited. More work is needed to dissect the
signalling pathway of CXCL12-induced migration.
When we compared the gene expression proﬁle of lung
and blood T cells in a 6000 gene microarray, we found
that Rac2 was consistently more expressed by T cells from
the blood, whereas the Rho was preferentially expressed
by lung T cells. The balance between Rac and Rho has
been shown to be important for cell migration.
28 Treat-
ment of a brain cancer cell line with an inhibitor which
caused down-regulation of Rac and up-regulation of Rho
led to a signiﬁcant decrease in mobility.
29 It is therefore
possible that the Rho/Rac imbalance present in lung T
cells could have inﬂuenced their migration within the col-
lagen matrix.
In summary, we demonstrated that in a three-dimen-
sional migration model, T cells derived from lung tissue
have a migratory phenotype distinct from that of blood T
cells, particularly in terms of their response to chemoattr-
actant signals. We also found that chemotaxis of blood T
cells to CXCL12 in this type of assay is independent of
PI3K activity.
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Movie S1. Representative time-lapse movie of the spon-
taneous migration of 24-hr cultured peripheral blood T
cells in a three-dimensional collagen matrix.
Movie S2. Representative time-lapse movie showing the
directional migration within a 3D collagen matrix of 24-
hr cultured T cells from peripheral blood in response to a
gradient of CXCL12. 100 ng/ml of the chemokine was
added to the right side of the polymerized gel immedi-
ately before ﬁlming.
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